Naseem Amin

Insider Reports History

Location
Hampton, NJ
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naseem Amin:

Company Role Class Num Shares Value Price $ Report Date Ownership
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 22,000 $208,340 $9.47 29 Jul 2025 Direct
Bellerophon Therapeutics, Inc. Director Common Stock 291,865 $30,296 $0.1038 07 Jun 2023 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 11,000 29 Jul 2025 Direct

Insider Reports Filed by Naseem Amin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVDL AVADEL PHARMACEUTICALS PLC 29 Jul 2025 2 $0 4 Director 31 Jul 2025, 16:06
AVDL AVADEL PHARMACEUTICALS PLC 30 Jul 2024 2 $0 4 Director 01 Aug 2024, 16:35
AVDL AVADEL PHARMACEUTICALS PLC 17 May 2024 1 $0 4 Director 21 May 2024, 17:29
AVDL AVADEL PHARMACEUTICALS PLC 17 May 2024 0 $0 3 Director 21 May 2024, 17:27
BLPH Bellerophon Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:12
BLPH Bellerophon Therapeutics, Inc. 10 Feb 2023 1 $0 4 Director 14 Feb 2023, 18:32
BLPH Bellerophon Therapeutics, Inc. 31 Dec 2021 2 $26,880 4 Director 04 Jan 2022, 15:10